NCT01048203View on ClinicalTrials.gov

A Single Dose Metabolism and Mass Balance Study of 14C-ABR-215050 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

6

Participants

Timeline

Start Date

January 31, 2009

Primary Completion Date

March 31, 2009

Study Completion Date

March 31, 2009

Conditions

Healthy

Interventions

DRUG

ABR-215050

1 mg ABR-215050

Trial Locations (1)

582 25

JJ Berzelius Clinical Research Center AB, Berzelius Science Park, Linköping

Sponsors

Lead Sponsor

Active Biotech AB

All Listed Sponsors

lead

Active Biotech AB

INDUSTRY